Therapeuticsmd, inc. (TXMD)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss

-56,848

-49,435

-31,966

-55,236

-39,506

-39,390

-35,605

-33,219

-24,401

-21,427

-14,664

-19,676

-21,156

-22,836

-25,015

-21,094

-20,929

-17,482

-19,472

-27,227

-20,894

-16,302

-17,832

-10,899

-9,183

-8,379

-7,654

-6,009

-6,375

-5,727

-4,253

-11,850

-13,289

-9,585

-1,486

-1,066

-774

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of fixed assets

198

191

90

66

66

59

42

40

38

36

35

35

33

32

26

10

8

7

7

7

6

6

7

8

7

6

29

7

4

6

6

8

7

-

-

-

-

Amortization of intangible assets

63

57

51

48

40

35

31

24

21

19

18

17

16

15

13

13

11

10

8

6

6

6

5

5

5

0

3

3

3

6

8

6

7

-

-

-

-

Non-cash operating lease expense

351

350

268

223

219

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13

13

13

(Recovery of) provision for doubtful accounts

-122

212

-72

85

82

-15

193

15

22

2

19

-16

-1

263

1,814

211

236

-15

6

17

13

-8

1

-4

6

-63

-9

36

21

7

18

15

0

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

197

-197

0

-10,307

-7,390

0

0

0

Amortization of debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,102

444

50

1,055

53

10

14

3

0

Share-based compensation

2,366

2,834

2,635

2,637

2,586

2,273

2,260

2,377

1,751

1,851

1,986

1,638

1,413

4,025

4,184

4,819

4,381

2,448

1,772

2,128

840

1,035

1,666

1,259

1,009

1,917

747

637

542

836

502

440

88

37

54

45

52

Amortization of deferred financing fees

319

273

265

196

120

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

260

395

396

395

263

-

0

0

0

-

-

-

-

Amortization of license fee

745

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock based expense for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

166

314

-

167

458

178

105

112

64

55

22

0

0

0

Loan guaranty costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

2

9

11

11

11

11

11

11

2

Changes in operating assets and liabilities:
Accounts receivable

-3,854

9,284

-3,131

3,523

3,963

-1,754

7,370

544

790

-61

1,015

-541

-580

-269

2,370

-375

2,250

-631

359

687

502

-2

-14

-179

654

-166

825

391

17

451

-119

310

85

36

0

-8

-12

Inventory

2,746

1,327

3,038

2,538

1,688

889

497

259

135

191

-120

75

262

232

-40

-73

267

-179

-378

289

-222

170

-441

532

-122

-103

-358

168

-277

660

134

277

-45

177

-206

59

-60

Other current assets

-

-

-

-

-

-

1,305

-1,033

-1,506

3,602

773

-194

253

-329

621

-523

-477

151

1,005

-291

-91

-482

-658

374

85

-540

230

1,695

0

-71

-89

170

-51

347

3

-10

5

Other current assets

-4,436

-

-

-

-987

-

-

-

-

-

-

-

-

-

-

-

2

2

2

2

9

20

-1

9

9

-419

85

899

0

-

-

-

-

-

-

-

-

Accounts payable

9,533

-4,952

4,634

-5,866

2,621

11,361

-45

5,143

2,186

-101

-3,908

1,961

-1,212

3,134

1,185

-391

304

-2,175

-516

-416

-91

678

3,318

-738

954

-357

426

204

199

610

338

84

301

50

24

109

4

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

82

87

45

-

0

0

0

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-522

-325

-439

-190

-124

-249

633

71

2

1,846

-83

-618

0

-

-

-

-

Accrued expenses and other current liabilities

-1,261

10,272

600

2,532

268

436

8,109

409

152

2,546

1,497

-2,760

316

-619

1,943

134

-1,373

1,152

498

1,008

1,038

-670

1,181

1,057

-1,329

1,685

731

168

290

705

-314

301

-52

497

49

39

7

Other long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

246

315

651

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-39,110

-50,797

-26,222

-50,514

-38,163

-28,144

-34,067

-24,949

-19,649

-20,805

-16,684

-18,139

-20,525

-15,617

-18,799

-15,321

-19,403

-16,609

-18,437

-24,847

-19,149

-15,285

-11,457

-10,072

-8,705

-4,768

-5,314

-7,176

-3,508

-4,006

-3,081

-3,197

-2,451

-1,884

-1,519

-801

-760

CASH FLOWS FROM INVESTING ACTIVITIES
Patent costs

421

373

305

359

403

356

314

292

142

325

72

260

107

303

148

302

90

301

39

41

36

393

-19

115

97

181

145

31

80

117

39

37

12

8

0

0

0

Purchase of fixed assets

21

360

996

830

262

150

20

18

26

25

0

8

27

88

42

190

74

-

-

-

-

0

0

7

23

17

0

0

22

-2

2

34

32

0

2

15

10

Payment of security deposit

-

-

-

-

-

163

-0

0

11

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-443

-20,734

-1,302

-1,210

-665

-671

-20,334

-311

-180

-351

-72

-268

-135

-392

-200

-498

-165

-450

-39

-57

-36

-382

9

-112

-120

-302

-21

-156

-103

-115

-41

-71

-44

1

247

-275

-10

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of options and warrants

72

0

8

0

100

429

107

1,084

44

0

0

20

192

10

1

191

786

642

98

484

7

30

28

247

40

24

0

6

0

0

25

0

165

-

-

-

-

Proceeds from revolving credit note

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Repayment of revolving credit note

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Proceeds from sale of common stock, net of costs

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

134,863

0

32,256

0

59,117

-

-

-

0

-334

30,472

3,081

45,430

7,770

125

0

0

-

-

-

-

Proceeds from exercise of warrants

-

-

-

-

-

-

-

-

-

0

0

1,338

2,460

0

0

63

1,310

0

0

7

358

0

94

87

0

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from notes and loans payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

100

0

1,800

4,500

2,400

688

1,345

382

267

Proceeds from sale of membership units

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

607

100

Proceeds from Financing Agreement

50,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

100

400

-

-

-

-

-

-

-

-

Payment of deferred financing fees

1,250

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of bank line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

100

400

-

-

-

-

-

-

-

-

Repayment of notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

4,691

1,799

0

50

0

197

0

2

0

Net cash provided by financing activities

48,822

77,031

8

111,687

100

429

90,015

72,298

44

0

68,572

1,359

2,652

10

1

254

136,959

642

32,355

491

59,483

30

42,893

334

40

-309

30,472

2,988

40,838

5,521

1,950

4,400

2,565

1,855

1,347

1,137

367

Increase (decrease) in cash

9,268

5,499

-27,516

59,962

-38,729

-28,386

35,612

47,037

-19,786

-21,157

51,816

-17,048

-18,008

-15,999

-18,998

-15,564

117,390

-16,417

13,878

-24,412

40,296

-15,637

31,445

-9,850

-8,786

-5,381

25,136

-4,344

37,226

1,399

-1,172

1,131

68

-27

75

59

-404

Supplemental disclosure of cash flow information
Interest paid

5,892

5,341

5,457

5,075

1,913

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

21

191

-19

29

5

2

0

0

0

0

Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

Warrants issued for financing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,711

-

-

-

-

-

-

-

-